Fourth quarter total revenues
increased 14% year-over-year; total revenues
increased 22% excluding MRI asset sale

Conference call today
at 4:30 p.m. ET

NASHUA, N.H. (March 22, 2018) – iCAD, Inc. (NASDAQ: ICAD), an industry-leading
provider of advanced image analysis, workflow solutions and radiation therapy
for the early identification and treatment of cancer, today reported financial
results for the three and twelve months ended December 31, 2017.

View Webcast
Full Results